Navigation Links
InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing

HUNTSVILLE, Ala. and MARLBOROUGH, Mass., Aug. 3 /PRNewswire/ -- InQ Biosciences Corporation, a provider of innovative technologies for cell growth and research, announced the appointment of John Ryder as Senior Vice President, Sales and Marketing. Ryder will be based in InQ's sales office in Marlborough, Massachusetts.

"Mr. Ryder's responsibilities will include developing our sales channels, creating a strategic marketing plan, and building the InQ brand around the world," said Dick Reeves, Chairman and Chief Executive Officer, InQ Biosciences.

"With his deep life sciences experience, he is the ideal executive to help us commercialize and launch the InQ Cell Research System. We are locating Mr. Ryder in the Boston area -- the center of the stem cell and neuroscience research markets that will so greatly benefit from our exciting new technology," Reeves said.

InQ is the first fully integrated system that creates a true in vivo environment for studying sensitive nerve, brain, and other human cells for disease research. It is the only cell research instrument that combines a dynamic software-controlled sample environment with powerful imaging and real-time data collection. These unique capabilities enable researchers to achieve unprecedented cell culture control, viability, and visibility that was previously unattainable.

Ryder brings over 20 years of life science sales, marketing, and business development leadership to InQ Biosciences. He joined the company from Skyscape, Marlborough, Massachusetts, a provider of trusted medical information for hand-held and mobile devices, where he was Senior Vice President of Sales. In that role, Ryder was instrumental in facilitating the acquisition of Skyscape in July 2009 by Physicians Interactive and Perseus, a $2 billion private equity firm. He also led sales and marketing for Advanced Instruments, Norwood, Massachusetts, a leading provider of microbiology research instrumentation to the pharmaceutical, industrial, and research markets. In addition, Ryder held sales management positions with Baxter Healthcare, Becton Dickinson Corporation, and Fisher Scientific. He holds a BS degree in Health Science Education from Springfield College in Massachusetts.

About InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company's InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ system is scheduled for the fourth quarter of 2010. For more information, visit Follow InQ Biosciences on Twitter at @InQbio (

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Aaron Hammons

SOURCE InQ Biosciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
2. Award Winning Mayo Clinic Scientist Joins Cardio3 BioSciences
3. SeqWrights Partnership with EraGen Biosciences Contributes to FDA Market Clearance Success
4. Signum Biosciences, Inc. Announces Commercial Launch of Arazineā„¢
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
6. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
7. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
8. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
9. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
10. Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference
11. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
Post Your Comments:
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
Breaking Medicine Technology:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):